1. "Gastrointestinal Oncology Service"
Formats
  1. Journal Article (2302)
  2. Meeting Abstract (1841)
  3. Review (139)
  4. Book Section (123)
  5. Editorial (93)
  6. Guidelines (36)
  7. Correspondence (33)
  8. Conference Paper (23)
  9. Miscellaneous (21)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Gastrointestinal Oncology Service (4640)
  2. Solid Tumor Oncology Division (4640)
  3. Department of Medicine (4638)
  4. Center for Pancreatic Cancer Research (2270)
  5. Surgery (1040)
  6. Survivorship Research (992)

More Groups

People
  1. Leonard Saltz (790)
  2. Eileen O'Reilly (780)
  3. Ghassan Abou-Alfa (568)
  4. Nancy Kemeny (543)
  5. David Kelsen (537)
  6. David Ilson (433)

More People

Years
  1. 2025 (118)
  2. 2024 (307)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1276)
  2. Annals of Oncology (320)
  3. Annals of Surgical Oncology (140)
  4. Cancer (127)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1355)
  2. Oxford University Press (447)
  3. Elsevier Inc. (404)
  4. Springer (310)
  5. American Association for Cancer Research (279)
  6. Wiley Blackwell (239)

More Publishers

Results (4640)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Neoadjuvant or adjuvant therapy for resectable or borderline resectable pancreatic cancer: Which is preferred?
    Editorial

    O'Reilly, E. M.; Ferrone, C.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • An emerging paradigm for germline testing in pancreatic ductal adenocarcinoma and immediate implications for clinical practice: A review
    Review

    Rainone, M.; Singh, I.; Salo-Mullen, E. E.; Stadler, Z. K.; O'Reilly, E. M.
    JAMA Oncology (2020)

    Fulltext@MSK | Save
  • Research methods: Outcomes and survivorship research in geriatric oncology
    Book Section

    Shahrokni, A.; McMillan, S.; Alexander, K.
    In Extermann, M. (Eds.) Geriatric Oncology (2020)

    Fulltext@MSK | Save
  • BRAF-mutant transcriptional subtypes predict outcome of combined BRAF, MEK, and EGFR blockade with dabrafenib, trametinib, and panitumumab in patients with colorectal cancer
    Journal Article

    Middleton, G.; Yang, Y.; Campbell, C. D.; AndreĢ, T.; Atreya, C. E.; Schellens, J. H. M.; Yoshino, T.; Bendell, J. C.; Hollebecque, A.; McRee, A. J.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Comparative efficacy of cabozantinib and regorafenib for advanced hepatocellular carcinoma
    Journal Article

    Kelley, R. K.; Mollon, P.; Blanc, J. F.; Daniele, B.; Yau, T.; Cheng, A. L.; Valcheva, V.; Marteau, F.; Guerra, I.; Abou-Alfa, G. K.
    Advances in Therapy (2020)

    Fulltext@MSK | Save
  • The multidisciplinary management of early distal esophageal and gastroesophageal junction cancer
    Book Section

    Greally, M.; Ilson, D. H.
    In Saba, N. F.; El-Rayes, B. F. (Eds.) Esophageal Cancer: Prevention, Diagnosis and Therapy. 2nd ed (2020)

    Fulltext@MSK | Save
  • Immunotherapy in esophageal cancer
    Book Section

    Greally, M.; Ku, G. Y.
    In Saba, N. F.; El-Rayes, B. F. (Eds.) Esophageal Cancer: Prevention, Diagnosis and Therapy. 2nd ed (2020)

    Fulltext@MSK | Save
  • From theory to practice: Implementation of strategies to reduce acute care visits in patients with cancer
    Journal Article

    Daly, B.; Michaelis, L. C.; Sprandio, J. D.; Kapke, J. T.; Narra, R. K.; Malosh, E.; Zervoudakis, A.; Holland, J.; Zablocki, M.
    American Society of Clinical Oncology Educational Book (2020)

    Fulltext@MSK | Save
  • Retained mismatch repair protein expression occurs in approximately 6% of microsatellite instability-high cancers and is associated with missense mutations in mismatch repair genes
    Journal Article

    Hechtman, J. F.; Rana, S.; Middha, S.; Stadler, Z. K.; Latham, A.; Benayed, R.; Soslow, R.; Ladanyi, M.; Yaeger, R.; Zehir, A.; more...
    Modern Pathology (2020)

    Fulltext@MSK | Save
  • Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: A multicentre, open-label, phase 2 study
    Journal Article

    Abou-Alfa, G. K.; Sahai, V.; Hollebecque, A.; Vaccaro, G.; Melisi, D.; Al-Rajabi, R.; Paulson, A. S.; Borad, M. J.; Gallinson, D.; Murphy, A. G.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save